Immune to Cancer: The CRI Blog
-
Journey Through the Highlights of the 12th Annual Cancer Immunotherapy Month™
Each June, CRI invites its global community of scientists, caretakers, patients, and more to take part in… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption
“Just one for the road.” We’ve all heard or said this at a party. Alcohol is a… -
CRI’s 5th Annual Wear White Luncheon Raises Over $40,000
On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,… -
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
#Immune2Cancer Day Ignites Support for CRI
The cornerstone of Cancer Immunotherapy MonthTM is #Immune2Cancer Day, June 14, a day dedicated to showcasing the… -
CRI Associate Board Pours Out Hope at UnWINEd
On Thursday, June 13, 2024, the Cancer Research Institute (CRI) Associate Board hosted an unforgettable evening at… -
New Insights on CAR-T Design: Paving the Way for Broader Cancer Applications
The Cancer Research Institute (CRI) is excited to share the latest study from CRI Lloyd J. Old… -
Women in STEM: Shaping the Future Together
(STEM) stands for science, technology, engineering, and mathematics. STEM fields are at the forefront of driving innovation….
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.